Zscaler Operating Cash Flow decreased by 54.5% to $204.07M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.7%, from $179.43M to $204.07M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 48.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $73.37M | $44.74M | $93.27M | $48.26M | $77.24M | $103.14M | $128.46M | $89.48M | $108.47M | $135.94M | $260.81M | $142.07M | $173.41M | $203.56M | $331.34M | $179.43M | $211.08M | $250.60M | $448.28M | $204.07M |
| QoQ Change | — | -39.0% | +108.5% | -48.3% | +60.0% | +33.5% | +24.5% | -30.3% | +21.2% | +25.3% | +91.9% | -45.5% | +22.1% | +17.4% | +62.8% | -45.8% | +17.6% | +18.7% | +78.9% | -54.5% |
| YoY Change | — | — | — | — | +5.3% | +130.5% | +37.7% | +85.4% | +40.4% | +31.8% | +103.0% | +58.8% | +59.9% | +49.7% | +27.0% | +26.3% | +21.7% | +23.1% | +35.3% | +13.7% |